L302-1071 Screening compound: N-[(4-ethoxyphenyl)methyl]-3,3-dimethyl-1-(2-methylpropanoyl)-2,3-dihydro-1H-indole-5-sulfonamide

L302-1071 Screening compound: N-[(4-ethoxyphenyl)methyl]-3,3-dimethyl-1-(2-methylpropanoyl)-2,3-dihydro-1H-indole-5-sulfonamide
L302-1071 Screening compound: N-[(4-ethoxyphenyl)methyl]-3,3-dimethyl-1-(2-methylpropanoyl)-2,3-dihydro-1H-indole-5-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L302-1071
N-[(4-ethoxyphenyl)methyl]-3,3-dimethyl-1-(2-methylpropanoyl)-2,3-dihydro-1H-indole-5-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L302-1071

Molecular Formula

C23H30N2O4S (C23 H30 N2 O4 S)

Compound Name

N-[(4-ethoxyphenyl)methyl]-3,3-dimethyl-1-(2-methylpropanoyl)-2,3-dihydro-1H-indole-5-sulfonamide

IUPAC name

N-[(4-ethoxyphenyl)methyl]-33-dimethyl-1-(2-methylpropanoyl)-23-dihydro-1H-indole-5-sulfonamide

SMILES

CCOc1ccc(CNS(c(cc2)cc(C(C)(C)C3)c2N3C(C(C)C)=O)(=O)=O)cc1

InChI

InChI=1S/C23H30N2O4S/c1-6-29-18-9-7-17(8-10-18)14-24-30(27,28)19-11-12-21-20(13-19)23(4,5)15-25(21)22(26)16(2)3/h7-13,16,24H,6,14-15H2,1-5H3

InChI Key

DRMSVJUSEYMCMU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27242874

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

430.57

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.627

Distribution Coefficient, logD

4.627

Water Solubility, LogSw

-4.41

Polar Surface Area

65.004

Acid Dissociation Constant (pKa)

10.94

Base Dissociation Constant (pKb)

-3.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.50

L302-1071 in Drug Discovery

Included in Screening Libraries

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L302-1071 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L302-1071?
Check Price and Availability of L302-1071, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L302-1071 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L302-1071
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L302-1071
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L302-1071 available by request